Actively Recruiting

Phase Not Applicable
Age: 12Years - 21Years
FEMALE
Healthy Volunteers
ID05618054

Pediatric POTS: Does a Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?

Led by Virginia Commonwealth University · Updated on 2026-04-21

36

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating how individuals with Postural Tachycardia Syndrome (POTS) understand visual information to learn more about brain communication and its connection to POTS and its related health issues. This study focuses on females aged 12 to 21 years and aims to explore the role of the periaqueductal gray-vagus nerve interface in POTS. The research is sponsored by Virginia Commonwealth University and involves comparing adolescents with POTS to healthy peers. Participants will take part in a behavioral task called the looming task, where they view images during an fMRI scan and press a button when an image appears. This helps assess brain activity, particularly in the periaqueductal gray region, during both the task and resting periods. The study does not use randomization or blinding and includes healthy control participants without POTS or neurological disorders. During the study, participants will undergo fMRI scans lasting about 90 minutes for both the looming task and resting state to measure brain activation. Researchers will collect data on how different brain regions respond to visual stimuli and at rest. The total involvement includes these imaging sessions and may involve consent and communication assessments. The study monitors participants carefully to ensure safety and accurate data collection throughout the process.

CONDITIONS

Brief Title

Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?

Who Can Participate

Age: 12Years - 21Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Female aged 12 to 21 years
  • Able to communicate and provide consent or assent
  • English speaking
  • Diagnosed with POTS defined as a symptomatic heart rate rise of 40 bpm or more without blood pressure drop and with symptoms of orthostatic intolerance
  • Age-matched healthy controls without POTS or other neurological disorders
Not Eligible

You will not qualify if you...

  • Inflammatory arthritis, connective tissue, or autoimmune disorders
  • Any chronic neurological disorder other than POTS
  • Unstable medical disorders including kidney, liver, cardiovascular, respiratory, endocrine, or uncontrolled psychiatric illnesses
  • Neuropathy or central nervous system disorders such as cerebral palsy, seizure disorder, multiple sclerosis, or stroke
  • Use of unapproved drugs or medical devices in the past 30 days
  • Use of hormones except insulin, thyroid replacement, or oral contraceptives
  • Current substance or alcohol abuse
  • Recent major surgery with general anesthesia within 60 days or minor procedures with sedation within 7 days
  • Ongoing or pending medical, health, or disability litigation
  • Any condition interfering with informed consent, compliance, or study interpretation
  • Chronic use of narcotics for pain
  • Claustrophobia or metal hardware interfering with MRI
  • Investigators and study staff

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - 90 minutes

Participants undergo an fMRI scan while performing a looming task, which involves looking at pictures and pressing a button when an image appears to assess periaqueductal gray region activation.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Virginia Commonwealth University

Richmond, Virginia, United States, 23298

Actively Recruiting

Loading map...

Research Team

G

Gisela Chelimsky, M.D.

M

Madison Maxwell, B.S.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Similar Trials

Double-Blind, Placebo-Controlled Study of Pyridostigmine in ...

Postural Tachycardia Syndrome

Actively Recruiting

1 location

Autonomic Neuropathy and Its Pathophysiology in Autoimmune A...

Autonomic Neuropathy

Actively Recruiting

1 location

A Randomized Crossover Study of Propranolol Versus Ivabradin...

Postural Tachycardia Syndrome

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here